Blog

Fatty liver disease can follow very different paths—and someone’s weight or diabetes status may not reveal how serious their liver risk is. That is the main message of this study… Read more: Fatty Liver: 5 Patterns

The 10/14/2026 article titled “Recompensation may represent a new treatment-related state in cirrhosis” was published by the American Association for the Advancement of Science (AAAS). Recompensation means that someone whose… Read more: Recompensation

We just read the article titled “GLP-1-based treatments and long-term clinical outcomes in MASLD amongst older adults: a retrospective cohort study” from the 09/21/2026 edition of Age & Aging. GLP-1… Read more: MASLD, Seniors and GLP-1s

The main message from the article “Cardiovascular Complications of Chronic Liver Disease” is that liver disease can threaten your heart as well as your liver—and that connection is often overlooked.… Read more: Liver Health is Heart Health

Liver disease access in the USA?  Months-out, in person.  LiverRight makes it same-week, telemedicine. Refer to our clinic in all 50 states, and we’ll deliver on liver for YOUR patients. … Read more: Providers: How to Refer to LiverRight

In his October 7, 2026 Forbes article, “The Next Big Health Crisis May Be Hiding in Your Liver,” Dr. Peter Ubel highlights the growing public health threat of metabolic dysfunction–associated… Read more: Trouble in the Liver

Here’s an important LiverRight patient-education topic, because the intuitive consumer belief—“Tylenol affects the liver, therefore Advil must be safer for liver patients”—misses the much more important NSAID risk in advanced… Read more: OTC Pain Relievers and Your Liver

The article entitled “Liver Imaging System LI-RADS Emerges as a Powerful Prognostic Biomarker in Liver Cancer” from Bioengineer dated 10/03/2026 discusses a major shift in how doctors treat liver cancer… Read more: Why LI-RADS

The Bioengineer.com article “Older Donors, Warmer Organs: How the US Organ Recovery System Is Being Pushed to Its Limits” summarizes a 2026 review by Michigan Medicine transplant surgeons Christina Fleischer… Read more: Donor Organs at the Limit

See this 2026 Journal of Hepatology review titled “Surveillance of patients at risk of liver cancer: Expert opinions.” It asks an important question: Does routinely screening people at high risk… Read more: Liver-Cancer Surveillance

The article from NCQA on 09/25/2026 titled “Why Liver Health Belongs in the Cardiometabolic Conversation” argues that liver health belongs in routine cardiometabolic care. Obesity, type 2 diabetes, high blood… Read more: Liver and Cardiometabolic

The OHSU article titled “PATHFINDER 2 findings advance multi-cancer early detection blood testing” illuminates a blood test that helps increase cancer detection 6.5-fold, and identifies many cancers lacking routine screening… Read more: Multi-Cancer Early Detection Blood Testing

Being turned down for a liver transplant may no longer be the final answer. Penn Medicine is expanding eligibility for selected patients, including some with recent alcohol use, certain cancers,… Read more: More Transplants Eligibility

A large biopsy-confirmed study found that fatty liver–related cirrhosis is not limited to older adults. About one in four MASLD cirrhosis cases occurred before age 50. The key article is… Read more: MASLD Cirrhosis Before Age 50

Consider “Study Finds Why Young Adults May Develop Early Fatty Liver Disease (Genetics and type 2 diabetes can help identify individuals at risk for advanced liver disease before age 50,… Read more: Early-Onset Fatty Liver Disease Study

The article titled “For Liver Cancer, Screening, Not Treatment, Poses the Biggest Challenge” from US Medicine on 09/10/2026 indicates that liver cancer treatment has improved significantly, but the larger challenge… Read more: Screening in Liver Cancer

The Health Affairs article titled “The National Hepatitis C Plan Needs A Correctional-Care Standard” argues that the United States cannot eliminate hepatitis C without establishing a consistent national standard for… Read more: HCV and Corrections Care

LiverRight and AEGLE MEDICAL Solutions, LLC Form Strategic Partnership to Expand Access to Liver Disease Detection, Diagnosis and Care Collaboration combines AEGLE MEDICAL’s liver assessment technology solutions, nationwide implementation and… Read more: LiverRight and AEGLE MEDICAL Partner

This new Lancet Digital Health 09/04/2026 paper titled “Digital pathology, image analysis, and artificial intelligence in liver disease” is a broad review of how digital pathology and AI could improve… Read more: AI and Digital Pathology in Liver Disease

The HepMag article from 08/27/2026 titled “Rural Americans Face Worsening Liver Cancer Disparities” is revealing. The article highlights a growing rural–urban divide in hepatocellular carcinoma (HCC), the most common form… Read more: Rural Liver Cancer Disparities

HHS Announces Winners of the 2026 KidneyX EMPOWER: Living Link Prize Challenge to Advance Living Kidney Donation and Patient-Centered Innovation “WASHINGTON, D.C. — August 27, 2026 — The U.S. Department… Read more: KidneyX EMPOWER Winners

Find out soonest, we say.

The 2025 State of Steatotic Liver Care survey from the Steatotic Liver Foundation paints a clear picture: liver disease is still being detected too late, and many diagnosed patients never… Read more: State of Fatty Liver Care

This June 2026 article in Hepatobiliary & Pancreatic Diseases International titled “Combined Bio-histological assessment as a tool to refine diagnosis and avoid overtreatment of early T cell-mediated rejection after liver… Read more: Post Liver Transplant New Scoring Tool

Summary: Lean Fatty Liver May Still Carry Meaningful Liver Risk A large multinational study highlighted by GI & Hepatology News (Aug. 12, 2026), titled “Lean steatosis without metabolic risk factors… Read more: Lean Fatty Liver

The Liver Disease News article, “Signs your liver is healing from MASLD,” makes a useful patient-facing point: the liver can recover substantially—especially when MASLD is identified before advanced fibrosis/cirrhosis—but symptoms… Read more: Liver Healing

This study titled “Xenobiotic-Induced Liver Injury in the United States: A 25-Year Retrospective Analysis of National Poison Data System” looked at 25 years of U.S. poison-center data to see how… Read more: Poison-Center Data and Liver Injury